275
Participants
Start Date
April 12, 2016
Primary Completion Date
April 12, 2025
Study Completion Date
April 12, 2029
177Lu-Octreotate
"* The induction course will consist in 4 cycles at 8-10 weeks intervals.~* Concomitant amino acids will be administered for renal protection.~* Intra-arterial LuTate administration will be allowed in suitable cases.~* Dosimetry will be based on quantitative SPECT/CT imaging.~* In patients with hormonal symptoms, somatostatine analogues can be given between P-PRRT cycles."
CHU de Québec - Université Laval, Québec
CHU de Quebec-Universite Laval
OTHER